Go Pro

Aeluma, Inc. (NASDAQ:ALMU) Given Average Recommendation of "Moderate Buy" by Brokerages

Aeluma logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Aeluma has a “Moderate Buy” consensus from five brokerages, with three buy ratings, one strong-buy rating and one sell rating. The average 12-month price target is $25, though Freedom Broker recently lowered its target from $30 to $25.
  • The company signed a letter of intent for up to $30 million in CHIPS Act funding and expanded its relationship with Sumitomo Chemical Advanced Technologies, while holding approximately $56 million in cash to support planned fiscal 2027 capital expenditures.
  • Despite the potential growth catalysts, Aeluma remains unprofitable: it reported a fourth-quarter loss of $0.15 per share on just $0.58 million in revenue. Shares fell 13.9% to $11.57, reflecting continued execution and commercialization risks.
  • MarketBeat previews the top five stocks to own by October 1st.

Aeluma, Inc. (NASDAQ:ALMU - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the five brokerages that are covering the company, Marketbeat reports. One research analyst has rated the stock with a sell rating, three have assigned a buy rating and one has given a strong buy rating to the company. The average 1 year target price among brokerages that have updated their coverage on the stock in the last year is $25.00.

Several brokerages recently weighed in on ALMU. Weiss Ratings reissued a "sell (d-)" rating on shares of Aeluma in a research note on Friday, July 17th. Freedom Broker reduced their price objective on shares of Aeluma from $30.00 to $25.00 and set a "buy" rating on the stock in a research note on Thursday.

Read Our Latest Stock Analysis on Aeluma

Key Headlines Impacting Aeluma

Here are the key news stories impacting Aeluma this week:

  • Positive Sentiment: Freedom Broker maintained a Buy rating while lowering its price target from $30 to $25. The revised target still implies approximately 116% upside, signaling substantial potential if Aeluma’s growth initiatives succeed. Benzinga analyst rating report
  • Positive Sentiment: Aeluma signed a letter of intent for up to $30 million in CHIPS Act funding to support AI and advanced-computing manufacturing. The company also expanded its strategic relationship with Sumitomo Chemical Advanced Technologies, which could increase wafer capacity and support commercialization. Aeluma fiscal 2026 results announcement
  • Positive Sentiment: The company ended the period with approximately $56 million in cash, providing funding for planned fiscal 2027 capital expenditures of $10 million to $12 million and reducing near-term financing pressure. Analysts continue to carry a Moderate Buy consensus while Aeluma works toward broader commercialization. Aeluma selloff and commercialization outlook
  • Neutral Sentiment: The CHIPS funding remains a prospective award rather than guaranteed cash, so investors will likely monitor final approvals, spending execution and evidence that the expanded Sumitomo relationship produces customer or revenue growth. Aeluma CHIPS funding and capital expenditure plans
  • Negative Sentiment: Fiscal fourth-quarter results highlighted ongoing execution risk: Aeluma reported a $0.15 per-share loss on only $0.58 million of revenue, with a negative 115.57% net margin and negative 12.03% return on equity. The wider losses intensified concerns about profitability while the company remains in its commercialization phase. Aeluma fourth-quarter financial results

Aeluma Trading Down 13.9%

Shares of NASDAQ:ALMU traded down $1.86 during midday trading on Thursday, hitting $11.57. The stock had a trading volume of 1,726,244 shares, compared to its average volume of 933,450. The company has a market capitalization of $211.83 million, a PE ratio of -33.05 and a beta of 4.07. Aeluma has a 1 year low of $10.24 and a 1 year high of $31.79. The stock has a 50 day moving average price of $15.24 and a two-hundred day moving average price of $17.98.

Aeluma (NASDAQ:ALMU - Get Free Report) last announced its quarterly earnings results on Wednesday, September 16th. The company reported ($0.15) earnings per share (EPS) for the quarter. The company had revenue of $0.58 million during the quarter. Aeluma had a negative net margin of 115.57% and a negative return on equity of 12.03%.

Insiders Place Their Bets

In related news, Director Steven Denbaars sold 12,500 shares of the company's stock in a transaction on Wednesday, August 26th. The stock was sold at an average price of $13.84, for a total value of $173,000.00. Following the completion of the transaction, the director directly owned 357,709 shares in the company, valued at approximately $4,950,692.56. This represents a 3.38% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 14.70% of the company's stock.

Institutional Trading of Aeluma

Several hedge funds and other institutional investors have recently added to or reduced their stakes in ALMU. Squarepoint Ops LLC acquired a new position in shares of Aeluma during the 2nd quarter valued at about $269,000. Fortitude Advisory Group L.L.C. boosted its position in shares of Aeluma by 6.0% in the second quarter. Fortitude Advisory Group L.L.C. now owns 37,567 shares of the company's stock worth $829,000 after acquiring an additional 2,132 shares during the last quarter. JNBA Financial Advisors grew its holdings in Aeluma by 107.2% in the second quarter. JNBA Financial Advisors now owns 3,340 shares of the company's stock valued at $74,000 after purchasing an additional 1,728 shares during the period. Wedbush Securities Inc. purchased a new stake in Aeluma in the second quarter valued at approximately $1,135,000. Finally, Bank of America Corp DE acquired a new position in Aeluma during the second quarter worth approximately $509,000.

About Aeluma

(Get Free Report)

Aeluma, Inc is a semiconductor company that develops and manufactures high-performance components for communications, sensing, computing and other advanced technology applications. The company's technology is designed to support the production of semiconductor devices on large-area and nontraditional substrates, with the goal of improving performance, scalability and integration.

Aeluma's products and development efforts include photonic and optoelectronic components such as photodetectors and related devices used in optical communications, data centers, 3D sensing, artificial intelligence, aerospace and defense, automotive systems, and consumer electronics.

Featured Stories

Analyst Recommendations for Aeluma (NASDAQ:ALMU)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Aeluma Right Now?

Before you consider Aeluma, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aeluma wasn't on the list.

While Aeluma currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines